Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GIGYF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ASPRV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR86 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PINLYP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RDH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NOCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFPI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BIRC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBMS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF149 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on